<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34756088</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>22</Day></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>Culture-Independent Detection of Poliovirus in Stool Samples by Direct RNA Extraction.</ArticleTitle><Pagination><StartPage>e0066821</StartPage><MedlinePgn>e0066821</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00668-21</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/Spectrum.00668-21</ELocationID><Abstract><AbstractText>Laboratory surveillance for poliovirus (PV) relies on virus isolation by cell culture to identify PV in stool specimens from acute flaccid paralysis (AFP) cases. Although this method successfully identifies PV, it is time-consuming and necessitates the additional biorisk of growing live virus in an increasingly polio-free world. To reduce the risk of culturing PV, the Global Polio Laboratory Network (GPLN) must switch to culture-independent diagnostic methods with sensitivity at least equivalent to that of cell culture procedures. Five commercial nucleic acid extraction kits and one enrichment method were tested for PV extraction efficiency. RNA yield was measured using real-time reverse transcription (RT)-PCR. Based on greater RNA yield, compared with the other kits, the <i>Quick</i>-RNA viral kit was selected for further testing and was optimized using an RNA extraction procedure for stool suspensions. RNA extraction was retrospectively tested with 182 stool samples that had previously tested positive for PVs, in parallel with the standard GPLN virus isolation algorithm. After virus isolation or RNA extraction, real-time RT-PCR assays were performed. RNA extraction was significantly more sensitive than virus isolation (McNemar's test, <i>P</i> &lt; 0.001). Thereafter, the RNA extraction method was tested in parallel for 202 prospective samples; RNA extraction and virus isolation were not significantly different from each other (McNemar's test, <i>P</i> = 0.13). Direct RNA extraction was noninferior to current cell culture methods for detecting PV in stool samples. Our results show that direct RNA extraction can make downstream manipulation safer and can reduce the risk of accidental posteradication viral release. The method is amenable to implementation in a wide variety of polio laboratories. <b>IMPORTANCE</b> Successfully identifying poliovirus from acute flaccid paralysis (AFP) cases is a vital role of the Global Polio Laboratory Network to achieve the goals of the Global Polio Eradication Initiative. Currently, laboratory surveillance relies on virus isolation by cell culture to test for PV present in stool samples. Although this method can identify polioviruses, laboratories must switch to culture-independent methods to reduce the risk associated with growing live viruses in a soon-to-be polio-free world. By implementing this streamlined method, in combination with real-time RT-PCR, laboratories can quickly screen for and type polioviruses of programmatic importance to support the final stages of global polio eradication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harrington</LastName><ForeName>Chelsea</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2879-444X</Identifier><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeffries-Miles</LastName><ForeName>Stacey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerloff</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5696-8318</Identifier><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandelbaum</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cherokee Nation Assurance, contracting agency to the Division of Viral Diseases, Arlington, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Nikail</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>IHRC, Inc., contracting agency to the Division of Viral Diseases, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Cara C</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0003-2582-2476</Identifier><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vega</LastName><ForeName>Everardo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9045-2331</Identifier><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA extraction</Keyword><Keyword MajorTopicYN="N">culture-independent diagnostics</Keyword><Keyword MajorTopicYN="N">direct detection</Keyword><Keyword MajorTopicYN="N">polio eradication</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword><Keyword MajorTopicYN="N">rRT-PCR</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>10</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34756088</ArticleId><ArticleId IdType="pmc">PMC8579935</ArticleId><ArticleId IdType="doi">10.1128/Spectrum.00668-21</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diop OM, Kew OM, de Gourville EM, Pallansch MA. 2017. The Global Polio Laboratory Network as a platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory Networks. J Infect Dis 216(Suppl 1):S299–S307. doi:10.1093/infdis/jix092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix092</ArticleId><ArticleId IdType="pmc">PMC5853949</ArticleId><ArticleId IdType="pubmed">28838192</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutter PD, Hinman AR, Hegg L, King D, Sosler S, Swezy V, Hussey AL, Cochi SL. 2017. Transition planning for after polio eradication. J Infect Dis 216(Suppl 1):S287–S292. doi:10.1093/infdis/jix026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix026</ArticleId><ArticleId IdType="pmc">PMC5853549</ArticleId><ArticleId IdType="pubmed">28838183</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Kilpatrick DR, Nakamura T, Burns CC, Bukbuk D, Oderinde SB, Oberste MS, Kew OM, Pallansch MA, Shimizu H. 2015. Development of an efficient entire-capsid-coding-region amplification method for direct detection of poliovirus from stool extracts. J Clin Microbiol 53:73–78. doi:10.1128/JCM.02384-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02384-14</ArticleId><ArticleId IdType="pmc">PMC4290957</ArticleId><ArticleId IdType="pubmed">25339406</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales M, Tangermann RH, Wassilak SG. 2016. Progress toward polio eradication: worldwide, 2015–2016. MMWR Morb Mortal Wkly Rep 65:470–473. doi:10.15585/mmwr.mm6518a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6518a4</ArticleId><ArticleId IdType="pubmed">27171208</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood DJ, Hull B. 1999. L20B cells simplify culture of polioviruses from clinical samples. J Med Virol 58:188–192. doi:10.1002/(SICI)1096-9071(199906)58:2&lt;188::AID-JMV15&gt;3.0.CO;2-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9071(199906)58:2&lt;188::AID-JMV15&gt;3.0.CO;2-H</ArticleId><ArticleId IdType="pubmed">10335869</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Zhang Y. 2016. Isolation and characterization of vaccine-derived polioviruses: relevance for the Global Polio Eradication Initiative, p 213–226. In Martín J (ed), Poliovirus: methods and protocols. Springer Science+Business Media, New York, NY. doi:10.1007/978-1-4939-3292-4_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3292-4_10</ArticleId><ArticleId IdType="pubmed">26983736</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerloff N, Sun H, Mandelbaum M, Maher C, Nix WA, Zaidi S, Shaukat S, Seakamela L, Nalavade UP, Sharma DK, Oberste MS, Vega E. 2018. Diagnostic assay development for poliovirus eradication. J Clin Microbiol 56:e01624-17. doi:10.1128/JCM.01624-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01624-17</ArticleId><ArticleId IdType="pmc">PMC5786708</ArticleId><ArticleId IdType="pubmed">29212703</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu HM, Zheng DP, Zhang LB, Oberste MS, Kew OM, Pallansch MA. 2003. Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China. J Virol 77:10994–11005. doi:10.1128/jvi.77.20.10994-11005.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.77.20.10994-11005.2003</ArticleId><ArticleId IdType="pmc">PMC225006</ArticleId><ArticleId IdType="pubmed">14512548</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor P. 2009. Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication. Vaccine 27:2649–2652. doi:10.1016/j.vaccine.2009.02.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.02.071</ArticleId><ArticleId IdType="pubmed">19428874</ArticleId></ArticleIdList></Reference><Reference><Citation>Wassilak S, Pate MA, Wannemuehler K, Jenks J, Burns C, Chenoweth P, Abanida EA, Adu F, Baba M, Gasasira A, Iber J, Mkanda P, Williams AJ, Shaw J, Pallansch M, Kew O. 2011. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis 203:898–909. doi:10.1093/infdis/jiq140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiq140</ArticleId><ArticleId IdType="pmc">PMC3068031</ArticleId><ArticleId IdType="pubmed">21402542</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorley BR, Roberts JA. 2016. Isolation and characterization of poliovirus in cell culture systems. Methods Mol Biol 1387:29–53. doi:10.1007/978-1-4939-3292-4_4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3292-4_4</ArticleId><ArticleId IdType="pubmed">26983730</ArticleId></ArticleIdList></Reference><Reference><Citation>Aylward B, Yamada T. 2011. The polio endgame. N Engl J Med 364:2273–2275. doi:10.1056/NEJMp1104329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1104329</ArticleId><ArticleId IdType="pubmed">21675884</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonagurio DA, Coleman JW, Patibandla SA, Prabhakar BS, Tatem JM. 1999. Direct detection of Sabin poliovirus vaccine strains in stool specimens of first-dose vaccinees by a sensitive reverse transcription-PCR method. J Clin Microbiol 37:283–289. doi:10.1128/JCM.37.2.283-289.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.37.2.283-289.1999</ArticleId><ArticleId IdType="pmc">PMC84287</ArticleId><ArticleId IdType="pubmed">9889205</ArticleId></ArticleIdList></Reference><Reference><Citation>Previsani N, Tangermann RH, Tallis G, Jafari HS. 2015. World Health Organization guidelines for containment of poliovirus following type-specific polio eradication: worldwide, 2015. MMWR Morb Mortal Wkly Rep 64:913–917. doi:10.15585/mmwr.mm6433a5.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6433a5</ArticleId><ArticleId IdType="pubmed">26313474</ArticleId></ArticleIdList></Reference><Reference><Citation>Old MO, Martinez CV, Kwock D, Garcia J, Martin G, Chan C, Maldonado YA. 2003. Direct extraction of Sabin poliovirus genomes from human fecal samples using a guanidine thiocyanate extraction method. J Virol Methods 110:193–200. doi:10.1016/S0166-0934(03)00133-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-0934(03)00133-2</ArticleId><ArticleId IdType="pubmed">12798248</ArticleId></ArticleIdList></Reference><Reference><Citation>Tambini G, Andrus JK, Marques E, Boshell J, Pallansch M, de Quadros CA, Kew O. 1993. Direct detection of wild poliovirus circulation by stool surveys of healthy children and analysis of community wastewater. J Infect Dis 168:1510–1514. doi:10.1093/infdis/168.6.1510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/168.6.1510</ArticleId><ArticleId IdType="pubmed">8245537</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner TJ, Diop OM, Jorba J, Chavan S, Ahmed J, Anand A. 2018. Surveillance to track progress toward polio eradication: worldwide, 2016–2017. MMWR Morb Mortal Wkly Rep 67:418–423. doi:10.15585/mmwr.mm6714a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6714a3</ArticleId><ArticleId IdType="pmc">PMC5898223</ArticleId><ArticleId IdType="pubmed">29649187</ArticleId></ArticleIdList></Reference><Reference><Citation>Snider CJ, Diop OM, Burns CC, Tangermann RH, Wassilak SG. 2016. Surveillance systems to track progress toward polio eradication: worldwide, 2014–2015. MMWR Morb Mortal Wkly Rep 65:346–351. doi:10.15585/mmwr.mm6513a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6513a3</ArticleId><ArticleId IdType="pubmed">27054558</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Masujima S, Wakita T, Shimizu H. 2010. Development of a particle agglutination method with soluble virus receptor for identification of poliovirus. J Clin Microbiol 48:2698–2702. doi:10.1128/JCM.00207-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00207-10</ArticleId><ArticleId IdType="pmc">PMC2916603</ArticleId><ArticleId IdType="pubmed">20519462</ArticleId></ArticleIdList></Reference><Reference><Citation>Honeywood MJ, Jeffries-Miles S, Wong K, Harrington C, Burns CC, Oberste MS, Bowen MD, Vega E. 2021. Use of guanidine thiocyanate-based nucleic acid extraction buffers to inactivate poliovirus in potentially infectious materials. J Virol Methods 297:114262. doi:10.1016/j.jviromet.2021.114262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2021.114262</ArticleId><ArticleId IdType="pmc">PMC9437866</ArticleId><ArticleId IdType="pubmed">34384823</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeniji JA, Oragwa AO, George UE, Ibok UI, Faleye TOC, Adewumi MO. 2017. Preponderance of enterovirus C in RD-L20B-cell-culture-negative stool samples from children diagnosed with acute flaccid paralysis in Nigeria. Arch Virol 162:3089–3101. doi:10.1007/s00705-017-3466-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-017-3466-2</ArticleId><ArticleId IdType="pubmed">28691129</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. 2004. Polio laboratory manual, 4th ed. World Health Organization, Geneva, Switzerland.</Citation></Reference><Reference><Citation>Leggitt PR, Jaykus LA. 2000. Detection methods for human enteric viruses in representative foods. J Food Prot 63:1738–1744. doi:10.4315/0362-028x-63.12.1738.</Citation><ArticleIdList><ArticleId IdType="doi">10.4315/0362-028x-63.12.1738</ArticleId><ArticleId IdType="pubmed">11131900</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. 2007. S1. Supplement to the WHO Polio Laboratory Manual: an alternative test algorithm for poliovirus isolation and characterization. World Health Organization, Geneva, Switzerland.</Citation></Reference><Reference><Citation>World Health Organization. 2015. The 21st Informal Consultation on the Global Polio Laboratory Network 25. World Health Organization, Geneva, Switzerland.</Citation></Reference><Reference><Citation>Liu HM, Zheng DP, Zhang LB, Oberste MS, Pallansch MA, Kew OM. 2000. Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol 74:11153–11161. doi:10.1128/JVI.74.23.11153-11161.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.23.11153-11161.2000</ArticleId><ArticleId IdType="pmc">PMC113202</ArticleId><ArticleId IdType="pubmed">11070012</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J. 2016. Phylogenetic analysis of poliovirus sequences. Methods Mol Biol 1387:227–237. doi:10.1007/978-1-4939-3292-4_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3292-4_11</ArticleId><ArticleId IdType="pubmed">26983737</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J, Campagnoli R, De L, Kew O. 2008. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol 82:4429–4440. doi:10.1128/JVI.02354-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02354-07</ArticleId><ArticleId IdType="pmc">PMC2293050</ArticleId><ArticleId IdType="pubmed">18287242</ArticleId></ArticleIdList></Reference><Reference><Citation>Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403–410. doi:10.1016/S0022-2836(05)80360-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2836(05)80360-2</ArticleId><ArticleId IdType="pubmed">2231712</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. 2016. R: a language and environment for statistical computing, v3.3.1. R Foundation for Statistical Computing, Vienna, Austria.</Citation></Reference><Reference><Citation>Fagerland MW, Lydersen S, Laake P. 2013. The McNemar test for binary matched-pairs data: mid-p and asymptotic are better than exact conditional. BMC Med Res Methodol 13:91. doi:10.1186/1471-2288-13-91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-13-91</ArticleId><ArticleId IdType="pmc">PMC3716987</ArticleId><ArticleId IdType="pubmed">23848987</ArticleId></ArticleIdList></Reference><Reference><Citation>Trajman A, Luiz RR. 2008. McNemar χ2 test revisited: comparing sensitivity and specificity of diagnostic examinations. Scand J Clin Lab Invest 68:77–80. doi:10.1080/00365510701666031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365510701666031</ArticleId><ArticleId IdType="pubmed">18224558</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H. 2009. ggplot2: elegant graphics for data analysis. Springer Science+Business Media, New York, NY.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>